DOCSLIB.ORG

Phytotoxicity, Morphological, and Metabolic Effects of The

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Phytotoxicity, Morphological, and Metabolic Effects of The plants Article Phytotoxicity, Morphological, and Metabolic Effects of the Sesquiterpenoid Nerolidol on Arabidopsis thaliana Seedling Roots 1, 2, 3 3 Marco Landi y , Biswapriya Biswavas Misra y , Antonella Muto , Leonardo Bruno and Fabrizio Araniti 4,* 1 Department of Agriculture, Food and Environment, University of Pisa, 56126 Pisa, Italy; [email protected] 2 Independent Researcher, Pine 211, Raintree Park Dwaraka Krishna, Namburu AP-522508, India; [email protected] 3 Dipartimento di Biologia, Ecologia e Scienze della Terra (DiBEST), Università della Calabria, 87040 Arcavacata di Rende, CS, Italy; [email protected] (A.M.); [email protected] (L.B.) 4 Department AGRARIA, University Mediterranea of Reggio Calabria Località Feo di Vito, 89124 Reggio Calabria, RC, Italy * Correspondence: [email protected] Both authors equally contributed to the manuscript. y Received: 26 August 2020; Accepted: 10 October 2020; Published: 12 October 2020 Abstract: Natural herbicides that are based on allelopathy of compounds, can offer effective alternatives to chemical herbicides towards sustainable agricultural practices. Nerolidol, a sesquiterpenoid alcohol synthesized by many plant families, was shown to be the most effective allelopathic compound in a preliminary screening performed with several other sesquiterpenoids. In the present study, Arabidopsis thaliana seedlings were treated for 14 d with various cis-nerolidol concentrations (0, 50, 100, 200, 400, and 800 µM) to investigate its effects on root growth and morphology. To probe the underlying changes in root metabolome, we conducted untargeted gas chromatography mass spectrometry (GC-MS) based metabolomics to find out the specificity or multi-target action of this sesquiterpenoid alcohol. Oxidative stress (measured as levels of H2O2 and malondialdehyde (MDA) by-product) and antioxidant enzyme activities, i.e., superoxide dismutase (SOD) and catalase (CAT) were also evaluated in the roots. Nerolidol showed an IC50 (120 µM), which can be considered low for natural products. Nerolidol caused alterations in root morphology, brought changes in auxin balance, induced changes in sugar, amino acid, and carboxylic acid profiles, and increased the levels of H2O2 and MDA in root tissues in a dose-dependent manner. Several metabolomic-scale changes induced by nerolidol support the multi-target action of nerolidol, which is a positive feature for a botanical herbicide. Though it warrants further mechanistic investigation, nerolidol is a promising compound for developing a new natural herbicide. Keywords: phytotoxicity; herbicide; root morphology; sesquiterpene alcohol; metabolomics 1. Introduction Weeds are one of the major threats to global agroecosystems, as they affect both crop productivity and quality [1]. The use of synthetic herbicides that are easy to apply and are economically accessible to farmers, is one of the popular and effective methods of weed management [2]. Nevertheless, the excessive use of chemical herbicides has negatively influenced the ecological equilibrium and human health [3]. Moreover, it has been clearly demonstrated that the majority of the known herbicides Plants 2020, 9, 1347; doi:10.3390/plants9101347 www.mdpi.com/journal/plants Plants 2020, 9, 1347 2 of 19 target a single specific metabolic action site [4–6], which is the main factor resulting in a rapidly evolving resistance to these synthetic chemicals. Herbicides with new mechanisms of action are extremely needed to counter this rapidly increasing evolution of herbicide resistance [7]. In addition, the attention of the public to possible hazardous effects of chemical herbicide to human health is continuously increasing, and new research activities are actively moving toward the search of naturally-derived herbicides, based on the allelopathic properties of some natural compounds [8–10]. Nowadays, it is of utmost importance for the use of a combination of agronomic, physical, mechanical, and chemical strategies for weed control in an Integrated Weed Management System (IWMS) [11,12] framework. In particular, the prospect of using secondary plant metabolites as natural herbicides, or as the backbone for herbicide discovery programs is becoming an effective alternative to the classic synthetic herbicides [13]. Natural compounds can effectively inhibit weed performances, act simultaneously on specific, and in most cases, multiple targets [14–17]. This ability to alter plant metabolism at different biochemical checkpoints increase the effectiveness of these compounds, but at the same time, it renders the identification of their main and most effective modes of action challenging [18]. Moreover, the chemical structure of natural products is generally more complex than synthetic herbicides, which means that they would not be easily obtained by traditional synthetic approaches based on massive chemical syntheses with the production of countless compounds whose biological activity is totally unknown [19]. Nerolidol (C15H26O; MW, 222.37 Da; IUPAC: 3,7,11-Trimethyl-1,6,10-dodecatrien-3-ol; also known as peruviol and penetrol), is a naturally occurring sesquiterpene alcohol found in the essential oils of diverse plants and flowers [20], and contributes to the fragrance/essence of the plants. This compound is largely studied for its multi-faceted pharmacological and biological activities [20–22] as well. Other compounds belonging to the sesquiterpenoid classes have shown a strong herbicidal activity [14,23]. In addition, nerolidol has already been mentioned as an important component of Asteraceae essential oil, whose natural herbicide activity was demonstrated [24]. Further, in our pilot studies, we have found that nerolidol resulted as a promising candidate among other sesquiterpenes (unpublished data) for allelopathy. Many allelochemicals, as stress inducers in acceptor plants, cause morphological alterations, and reduce weed germination and vigor [17,23,25–27]. However, their effectiveness in germination and growth inhibition of the weeds is, in most cases, the result of more complex metabolic alteration induced in the affected plants [16,27]. It is, therefore, essential to understanding the biochemical mechanism of action of these naturally-derived compounds for a future application as either a whole molecule, as a co-formulant, or as a backbone for a derived herbicide. In the present study, we focused on the effects of nerolidol on root morphology and root metabolome of Arabidopsis thaliana (L.) Heynh. Columbia-0 seedlings were treated for 14 d with a range of concentrations of this sesquiterpene alcohol. We also probed the effects of this compound on auxin balance to understand the underlying mechanism(s) responsible for the nerolidol-induced root alterations and the associated strong growth inhibition to elucidate the single- or multi-target activity of this potential allelochemical herbicide. 2. Materials and Methods 2.1. Root Bioassays in Arabidopsis thaliana Col-0 Cis-Nerolidol (Sigma-Aldrich, Milan, Italy, Cat. No. 72180-25ML) was firstly dissolved in 0.1% EtOH (ethanol, v/v) and was then diluted in deionized ddH2O to reach the final concentrations of: 0, 50, 100, 200, 400 and 800 µM. The same amount of EtOH was added to the control treatments (0 µM nerolidol). Arabidopsis seed sterilization and synchronization of the germination process were carried out as previously described by Araniti et al. [28]. To evaluate the phytotoxic effect of nerolidol on root morphology, seeds of Arabidopsis were germinated on Petri dishes (100 150 mm) containing agar × Plants 2020, 9, 1347 3 of 19 medium (0.8% w/v), enriched with micro- and macronutrients (Murashige-Skoog basal salt mixture, Sigma-Aldrich, Milan, Italy, Cat. No. M5524-50L) and supplemented with 1% sucrose as carbon source. Then, petri plates were transferred to a growth chamber (21 2 C temperature and 75 mol m 2 s 1 ± ◦ · − − light intensity). Immediately after germination of five seedlings, for each replicate and treatment, seedlings were transferred on treated Plates prepared as previously described. After 14 d of treatments the whole root system was imaged by scanning (STD 1600, Régent Instruments Inc., Quebec, QC, Canada) and Primary Root Length (PRL), and Number of Lateral Roots (NLR) were measured using WinRhizo Pro system v. 2002a (Instruments Régent Inc., Quebec, QC, Canada), whereas Root Hair Density (RHD) and Root Hair Length (RHL) were analyzed using a stereo-microscope (Olympus SZX9, Italy) and the software Image Pro Plus v6 (Media Cybernetics, Rockville, MD, USA). 2.2. Quantification of Indole-3-Acetic Acid (IAA) Quantification of indole-3-acetic acid (IAA) quantification was carried out following the method proposed by Rawlinson et al. [29] with some modifications. Arabidopsis roots were cut with a sharp blade below the hypocotyl, and were immediately frozen in liquid nitrogen, ground to a fine powder and were aliquoted. Further, weighed amounts of the powder (100 mg) per treatment and replicate were poured into 2 mL microcentrifuge tubes for extraction. To the samples, 20 µL of a 20 mg/mL solution of 3-indolepropionic acid (IPA) was added as internal standard for quantification and normalization purposes. Successively, 200 µL of NaOH (1% w/v), 147 µL of methanol (MeOH) and 34 µL of pyridine were added and the samples were vortexed for 40 s. To the extracted samples 20 µL of methyl chloroformate were added and samples were again vortexed for 30 s (and this step was repeated twice). To this extract, 400 µL of chloroform was added, samples were shaken for
Load more

Recommended publications
  • 268 Part 522—Implantation Or Injectable Dosage Form
    § 520.2645 21 CFR Ch. I (4–1–18 Edition) (ii) Indications for use. For the control 522.82 Aminopropazine. of American foulbrood (Paenibacillus 522.84 Beta-aminopropionitrile. larvae). 522.88 Amoxicillin. 522.90 Ampicillin injectable dosage forms. (iii) Limitations. The drug should be 522.90a Ampicillin trihydrate suspension. fed early in the spring or fall and con- 522.90b Ampicillin trihydrate powder for in- sumed by the bees before the main jection. honey flow begins, to avoid contamina- 522.90c Ampicillin sodium. tion of production honey. Complete 522.144 Arsenamide. treatments at least 4 weeks before 522.147 Atipamezole. main honey flow. 522.150 Azaperone. 522.161 Betamethasone. [40 FR 13838, Mar. 27, 1975, as amended at 50 522.163 Betamethasone dipropionate and FR 49841, Dec. 5, 1985; 59 FR 14365, Mar. 28, betamethasone sodium phosphate aque- 1994; 62 FR 39443, July 23, 1997; 68 FR 24879, ous suspension. May 9, 2003; 70 FR 69439, Nov. 16, 2005; 73 FR 522.167 Betamethasone sodium phosphate 76946, Dec. 18, 2008; 75 FR 76259, Dec. 8, 2010; and betamethasone acetate. 76 FR 59024, Sept. 23, 2011; 77 FR 29217, May 522.204 Boldenone. 17, 2012; 79 FR 37620, July 2, 2014; 79 FR 53136, 522.224 Bupivacaine. Sept. 8, 2014; 79 FR 64116, Oct. 28, 2014; 80 FR 522.230 Buprenorphine. 34278, June 16, 2015; 81 FR 48702, July 26, 2016] 522.234 Butamisole. 522.246 Butorphanol. § 520.2645 Tylvalosin. 522.275 N-Butylscopolammonium. 522.300 Carfentanil. (a) Specifications. Granules containing 522.304 Carprofen. 62.5 percent tylvalosin (w/w) as 522.311 Cefovecin.
    [Show full text]
  • Review Article
    REVIEW ARTICLE COLLAGEN METABOLISM COLLAGEN METABOLISM Types of Collagen 228 Structure of Collagen Molecules 230 Synthesis and Processing of Procollagen Polypeptides 232 Transcription and Translation 233 Posttranslational Modifications 233 Extracellular Processing of Procollagen and Collagen Fibrillogenesis 240 Functions of Collagen in Connective rissue 243 Collagen Degradation 245 Regulation of the Metabolism of Collagen 246 Heritable Diseases of Collagen 247 Recessive Dermatosparaxis 248 Recessive Forms of EDS 251 EDS VI 251 EDS VII 252 EDS V 252 Lysyl Oxidase Deficiency in the Mouse 253 X-Linked Cutis Laxa 253 Menke's Kinky Hair Syndrome 253 Homocystinuria 254 EDS IV 254 Dominant Forms of EDS 254 Dominant Collagen Packing Defect I 255 Dominant and Recessive Forms of Osteogenesis Imperfecta 258 Dominant and Recessive Forms of Cutis Laxa 258 The Marfan Syndrome 259 Acquired Diseases and Repair Processes Affecting Collagen 259 Acquired Changes in the Types of Collagen Synthesis 260 Acquired Changes in Amounts of Collagen Synthesized 263 Acquired Changes in Hydroxylation of Proline and Lysine 264 Acquired Changes in Collagen Cross-Links 265 Acquired Defects in Collagen Degradation 267 Conclusion 267 Bibliography 267 Collagen Metabolism A Comparison of Diseases of Collagen and Diseases Affecting Collagen Ronald R. Minor, VMD, PhD COLLAGEN CONSTITUTES approximately one third of the body's total protein, and changes in synthesis and/or degradation of colla- gen occur in nearly every disease process. There are also a number of newly described specific diseases of collagen in both man and domestic animals. Thus, an understanding of the synthesis, deposition, and turnover of collagen is important for the pathologist, the clinician, and the basic scientist alike.
    [Show full text]
  • 218 Part 522—Implantation Or Injectable Dosage Form
    Pt. 522 21 CFR Ch. I (4–1–07 Edition) by Mycoplasma gallisepticum sensitive 522.82 Aminopropazine fumarate sterile so- to tylosin. lution injection. (iii) Limitations. Do not use in layers 522.84 Beta-aminopropionitrile fumarate. 522.88 Sterile amoxicillin trihydrate for sus- producing eggs for human consump- pension. tion; administer from 2 to 5 days as 522.90 Ampicillin implantation and sole source of drinking water; treated injectible dosage forms. turkeys should consume enough medi- 522.90a Ampicillin trihydrate sterile suspen- cated drinking water to provide 60 mil- sion. ligrams of tylosin per pound of body 522.90b Ampicillin trihydrate for sterile sus- weight per day; prepare a fresh solu- pension. tion every 3 days; when sinus swelling 522.90c Ampicillin sodium for aqueous injec- tion. is present, inject the sinus with tylosin 522.144 Arsenamide sodium aqueous injec- injectable simultaneously with the tion. drinking water treatment; do not ad- 522.147 Atipamezole. minister within 5 days of slaughter. 522.150 Azaperone injection. (3) Swine—(i) Amount. 0.25 gram per 522.161 Betamethasone acetate and gallon. betamethasone disodium phosphate aque- (ii) Indications for use. For the control ous suspension. 522.163 Betamethasone dipropionate and and treatment of swine dysentery betamethasone sodium phosphate aque- (bloody scours) caused by pathogens ous suspension. sensitive to tylosin. 522.204 Boldenone. (iii) Limitations. As only source of 522.234 Butamisole hydrochloride. drinking water for 3 to 10 days, depend- 522.246 Butorphanol tartrate injection. ing on the severity of the condition 522.275 N-Butylscopolammonium bromide. being treated: mix fresh solution daily; 522.311 Carfentanil citrate injection.
    [Show full text]
  • Mutagens and Reproductive Toxins Chemical Class Standard Operating Procedure
    1 Mutagens and Reproductive Toxins Chemical Class Standard Operating Procedure Mutagens and Reproductive Toxins H340 H341 H360 H361 H362 This SOP is not a substitute for hands-on training. Print a copy and insert into your laboratory SOP binder. Department: Chemistry Date SOP was written: Thursday, July 1, 2021 Date SOP was approved by PI/lab supervisor: Thursday, July 1, 2021 Name: F. Fischer Principal Investigator: Signature: ______________________________ Name: Matthew Rollings Internal Lab Safety Coordinator or Lab Manager: Lab Phone: 510.301.1058 Office Phone: 510.643.7205 Name: Felix Fischer Emergency Contact: Phone Number: 510.643.7205 Tan Hall 674, 675, 676, 679, 680, 683, 684 Location(s) covered by this SOP: Hildebrand Hall: D61, D32 1. Purpose This SOP covers the precautions and safe handling procedures for the use of Mutagens and Reproductive Toxins. For a list of Mutagens and Reproductive Toxins covered by this SOP and their use(s), see the “List of Chemicals”. Procedures described in Section 12 apply to all materials covered in this SOP. A change to the “List of Chemicals” does not constitute a change in the SOP requiring review or retraining. If you have questions concerning the applicability of any recommendation or requirement listed in this procedure, contact the Principal Investigator/Laboratory Supervisor or the campus Chemical Hygiene Officer at [email protected]. 2. Physical & Chemical Properties/Definition of Chemical Group Germ Cell Mutagenicity is a hazard class that is primarily concerned with chemicals that may cause mutations in the germ cell of humans that can be transmitted to the progeny. Rev.
    [Show full text]
  • Rats by Fl-Aminopropionitrile (Hypertension/Blood Vessels) KAZUHIKO IWATSUKI, GEORGE J
    Proc. Nati. Acad. Sct. USA Vol. 74, No. 1, pp. 360-362, January 1977 Medical Sciences Reduction of blood pressure and vascular collagen in hypertensive rats by fl-aminopropionitrile (hypertension/blood vessels) KAZUHIKO IWATSUKI, GEORGE J. CARDINALE, SYDNEY SPECTOR, AND SIDNEY UDENFRIEND Roche Institute of Molecular Biology, Nutley, New Jersey 07110 Contributed by Sidney Udenfriend, October 21, 1976 ABSTRACT #-Aminopropionitrile, a specific inhibitor of Rats were killed by decapitation. The entire aorta and the lysyl oxidase preventedthe rise in blood pressure induced by mesenteric artery were excised from each animal and peri- deoxycorticosterone-salt in rats. In addition, after the onset of removed from them. Each hypertension, administration of P-aminopropionitrile lowered vascular adipose tissue was carefully the blood pressure. Concomitant with the lowering of blood vascular tissue was homogenized in 30 volumes of 0.5 M acetic pressure, there was a reduction in the more highly crosslinked acid in a ground-glass homogenizer, and the soluble collagen form of vascular collagen. These findings would indicate that was extracted for 24 hr at 40 (10). The extracts were centrifuged increases in vascular connective tissue are not only sequelae of at 11,500 X g for 30 min and the supernatants were dialyzed hyprtension, but may also contribute to the maintenance of against 10 mM acetic acid. The precipitates, containing the eevated blood pressure. insoluble collagen, were then lyophilized. After this, the su- vascular collagen biosynthesis pernatants and precipitates were hydrolyzed in 6 M HCl for We have previously reported that 20 hr at 105°. Hydroxyproline was measured by the method and deposition is increased in hypertensive rats and that these of Kivirikko et al.
    [Show full text]
  • WO 2013/020527 Al 14 February 2013 (14.02.2013) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/020527 Al 14 February 2013 (14.02.2013) P O P C T (51) International Patent Classification: (74) Common Representative: UNIVERSITY OF VETER¬ A61K 9/06 (2006.01) A61K 47/32 (2006.01) INARY AND PHARMACEUTICAL SCIENCES A61K 9/14 (2006.01) A61K 47/38 (2006.01) BRNO FACULTY OF PHARMACY; University of A61K 47/10 (2006.01) A61K 9/00 (2006.01) Veterinary and Pharmaceutical Sciences Brno Faculty Of A61K 47/18 (2006.01) Pharmacy, Palackeho 1/3, CZ-61242 Brno (CZ). (21) International Application Number: (81) Designated States (unless otherwise indicated, for every PCT/CZ20 12/000073 kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (22) Date: International Filing BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, 2 August 2012 (02.08.2012) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (25) Filing Language: English HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, (26) Publication Language: English ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (30) Priority Data: NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, 201 1-495 11 August 201 1 ( 11.08.201 1) SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, 2012- 72 1 February 2012 (01.02.2012) TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, 2012-5 11 26 July 2012 (26.07.2012) ZW.
    [Show full text]
  • Method and Use for Increasing Efficacy of Anti-Adhesive Compositions in Controlling Inflammation and Pain
    (19) & (11) EP 2 465 513 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 20.06.2012 Bulletin 2012/25 A61K 31/77 (2006.01) A61K 33/06 (2006.01) A61K 45/06 (2006.01) A61P 29/00 (2006.01) (21) Application number: 11195175.2 (22) Date of filing: 12.11.2007 (84) Designated Contracting States: (72) Inventor: Chamness, Kathy L. AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Memphis, TN 38104-5305 (US) HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR (74) Representative: O’Connell, Maura et al FRKelly (30) Priority: 13.11.2006 US 598397 27 Clyde Road Ballsbridge (62) Document number(s) of the earlier application(s) in Dublin 4 (IE) accordance with Art. 76 EPC: 07864257.6 / 2 104 505 Remarks: •This application was filed on 22-12-2011 as a (71) Applicant: Warsaw Orthopedic, Inc. divisional application to the application mentioned Warsaw, IN 46581 (US) under INID code 62. •Claims filed after the date of filing of the application (Rule 68(4) EPC). (54) Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain (57) The invention discloses a method and kit thereof prising an effective amount of at least one pharmaceuti- for increasing the efficiency of anti-adhesive composi- cally-acceptable anti-adhesive non-ionic polymer to a tions by parenterally administering a composition com- site of injury, controlling inflammation at the site of injury, and reducing pain. EP 2 465 513 A2 Printed by Jouve, 75001 PARIS (FR) EP 2 465 513 A2 Description FIELD OF THE INVENTION 5 [0001] The present invention relates to methods of increasing efficacy of anti-adhesive compositions by parental administration of compositions containing anti-adhesive polymers and magnesium salts.
    [Show full text]
  • WO 2017/180788 Al 19 October 2017 (19.10.2017) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/180788 Al 19 October 2017 (19.10.2017) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every Λ 61Κ 8/02 (2006.01) A61K 45/00 (2006.01) kind of national protection available): AE, AG, AL, AM, A61K 8/18 (2006.01) A61P 17/18 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, A61K 8/19 (2006.01) A61Q 19/00 (2006.01) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, A61K 33/00 (2006.01) C07K 14/78 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, A61K 38/00 (2006.01) HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, (21) International Application Number: MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, PCT/US20 17/027275 NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, (22) International Filing Date: RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, 12 April 2017 (12.04.2017) TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every (26) Publication Language: English kind of regional protection available): ARIPO (BW, GH, (30) Priority Data: GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, 62/321,626 12 April 2016 (12.04.2016) US TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, (71) Applicant: ILLUSTRIS PHARMACEUTICALS, INC.
    [Show full text]
  • Structure-Activity Relationship Analysis of the Subtype-Selective Sirt5 Inhibitor Balsalazide
    Dissertation zur Erlangung des Doktorgrades der Fakultät für Chemie und Pharmazie der Ludwig-Maximilians-Universität München Structure-activity relationship analysis of the subtype-selective Sirt5 inhibitor balsalazide Carina Glas aus Konstanz 2020 Erklärung Diese Dissertation wurde im Sinne von § 7 der Promotionsordnung vom 28. November 2011 von Herrn Prof. Dr. Franz Bracher betreut. Eidesstattliche Versicherung Diese Dissertation wurde eigenständig und ohne unerlaubte Hilfe erarbeitet. München, den 14.12.2020 ____________________ Carina Glas Dissertation eingereicht am: 14.12.2020 1. Gutachter: Prof. Dr. Franz Bracher 2. Gutachter: Prof. Dr. Manfred Jung Mündliche Prüfung am: 26.01.2021 Danksagung Mein herzlichster Dank gilt meinem Doktorvater Herrn Prof. Dr. Franz Bracher für die Möglichkeit, dieses vielseitige Thema in seinem Arbeitskreis bearbeiten zu dürfen. Vielen Dank für die gewährte Freiheit und die allzeit verfügbare Hilfe sowie die stetige Unterstützung während meines Studiums und der Promotion. Ich möchte mich bei den Mitgliedern meiner Prüfungskommission bedanken: Herrn Prof. Dr. Manfred Jung für die freundliche Übernahme des Koferats sowie Herrn Prof. Dr. Stefan Zahler, Herrn Prof. Dr. Christian Ochsenfeld, Herrn Prof. Dr. Paintner und Herrn Prof. Dr. Winter. Ein großer Dank gilt meinen Kooperationspartnern und deren Mitarbeitern: Prof. Dr. Christian Ochsenfeld, Prof. Dr. Manfred Jung, Prof. Dr. Wolfgang Sippl und Prof. Dr. Bernhard Küster. Insbesondere Johannes Dietschreit, Nathalie Wössner und Severin Lechner möchte ich für die großartige Zusammenarbeit danken. Den Analytikabteilungen danke ich für die zuverlässige Bearbeitung meiner Proben, egal, ob NMR (Claudia Glas und Dr. Lars Allmendinger), Masse (insb. Dr. Werner Spahl) oder Elementaranalyse. Martina Stadler danke ich für die Durchführung der MTT- und Agar- Diffusions-Tests und Anna Niedrig für die Messung der HPLC Reinheiten.
    [Show full text]
  • Chemical Safety and Waste Management Manual
    Chemical Safety and Waste Management Manual University of Alabama at Birmingham Department of Occupational Health & Safety Chemical Safety Division 2002 EDITION 1. INTRODUCTION In a comparatively short time, the University of Alabama at Birmingham has gained significant recognition as a center of excellence for teaching, medical services and research programs. This is a highly commendable achievement and one that could not have been realized without the continued support and dedication of faculty, staff members, and employees. Similar unfailing cooperation and support are necessary for the institution to be equally successful in its development of a comprehensive occupational health and safety program for the protection of University personnel, students, and the surrounding community. An important part of this program is concerned with the safe and prudent handling of chemicals and their proper legal disposal as regulated by the Environmental Protection Agency (EPA) and the Alabama Department of Environmental Management (ADEM). Almost every laboratory and many allied and support personnel at UAB use chemicals in their daily activities. It is the purpose of this manual to describe the operation of the Chemical Safety Program and to provide guidance in establishing safe work practices for the use of chemicals. This program applies to all work operations at this University where employees may be exposed to hazardous substances under normal working conditions or during an emergency. The Chemical Safety and Waste Management Manual combines both the Chemical Hygiene Plan for laboratories and the Hazard Communication Program for maintenance, environmental services, and other support personnel. The Occupational Safety and Health Administration (OSHA) Hazard Communication Standard may be found at : http://www.osha- slc.gov/OshStd_data/1910_1200.html.
    [Show full text]
  • Drug Repurposing for Schistosomiasis: Combinations of Drugs Or Biomolecules
    pharmaceuticals Review Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules Maria João Gouveia 1,2,3, Paul J. Brindley 4,Fátima Gärtner 3,5,6, José M. Correia da Costa 2,7 and Nuno Vale 1,* 1 UCBIO/REQUIMTE, Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo, 228, 4050-313 Porto, Portugal; [email protected] 2 Center for the Study of Animal Science, ICETA, University of Porto, Praça Gomes Teixeira, Apartado 55142, 4031-401 Porto, Portugal; [email protected] 3 Department of Molecular Pathology and Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal; [email protected] 4 Department of Microbiology, Immunology & Tropical Medicine, and Research Center for Neglected Diseases of Poverty, School of Medicine & Health Sciences, George Washington University, Washington, DC 20037, USA; [email protected] 5 Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Rua Júlio Amaral de Carvalho, 45, 4200-135 Porto, Portugal 6 Institute of Investigation and Innovation in Health (i3s), Rua Alfredo Allen, 4200-135 Porto, Portugal 7 Department of Infectious Diseases, INSA-National Health Institute Dr. Ricardo Jorge, Rua Alexandre Herculano 321, 4000-055 Porto, Portugal * Correspondence: [email protected]; Tel.: +351-220-428-606 Received: 25 October 2017; Accepted: 31 January 2018; Published: 5 February 2018 Abstract: Schistosomiasis is a major neglected tropical disease. Control of schistosomiasis currently relies on a single drug, praziquantel, and despite its efficacy against the all schistosome species that parasitize humans, it displays some problematic drawbacks and alone is ineffective in counteracting adverse pathologies associated with infection.
    [Show full text]
  • Product and Product Group Discharges Subject to Effluent Limitations and Standards
    PRODUCT AND PRODUCT GROUP DISCHARGES SUBJECT TO EFFLUENT LIMITATIONS AND STANDARDS for the ORGANIC CHEMICALS, PLASTICS, AND SYNTHETIC FIBERS POINT SOURCE CATEGORY - 40 CFR 414 April 2005 Office of Water U.S. Environmental Protection Agency 1200 Pennsylvania Ave., N.W. Washington, D.C. 20460 Table of Contents Section Page Introduction. 1 1 Summary of the 40 CFR 414 . .2 1.1 Regulated Parameters. 3 1.2 Requirements for Direct and Indirect Dischargers. 3 2. Identifying and Classifying Products Whose Production May be Subject to the OCPSF Regulation. 5 2.1 The SIC Manual and Codes . 5 2.2 Industrial Categories Applicable to Chemicals and Allied Products. .6 2.3 Part 414 Applicability to Production of Chemicals and Chemical Products. .6 2.4 Applicability of Wastewater from On-Site Auxiliary Operations. .8 2.5 General Discussion of OCPSF-Related Products Whose Manufacture May Not Be Regulated by Part 414 . .8 2.5.1 Products Classified and Previously Reported under Specific SIC Codes That Are Not Subject to Part 414 . .8 2.5.2 Products Listed in Part 414 That Are Regulated by Another Industrial Category Are Not Subject to Part 414 in Certain Circumstances . .10 2.5.2.1 Organic Chemicals Regulated by the Iron and Steel Category (40 CFR 420) . 10 2.5.2.2 Organic Chemicals Regulated by the Pesticides Chemicals Category (40 CFR 455). 11 2.5.2.3 Organic Chemicals Regulated by the Pharmaceutical Category. 11 2.5.2.4 Products Regulated by the Plastics Molding & Forming Category (40 CFR 463). 12 2.5.2.5 Organic Chemicals Regulated by the Soap and Detergent Category (40 CFR 417).
    [Show full text]